Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone gel in critically ill adult ICU patients
2017-004978-34Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of testosterone in critical illness and Hypoandrogenism (TD) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Aug 2018; status: completed.
02
Drugs
testosterone
03
Conditions
critical illnessHypoandrogenism (TD)
Beyond the preview
Go deeper on 2017-004978-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004978-34.